Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 151 to 165 of 489 results for 2011

  1. Shiley Endotracheal Tube with TaperGuard Cuff for intensive care patients at risk of ventilator‑associated pneumonia (MIB22)

    NICE has developed a medtech innovation briefing (MIB) on the Shiley Endotracheal Tube with TaperGuard Cuff .

    Medtech innovation briefing
    Published
    2 March 2015

  2. A trial comparing the long-term effectiveness (beyond 24 weeks) of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate and placebo would be beneficial. It should collect utility data as well as walking distance outcomes.

    peripheral arterial disease Number TA223 Date issued May 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  3. Which participatory approaches are most effective and cost effective among populations at higher risk of type 2 diabetes? This should consider the awareness, knowledge, understanding and skills of the providers of interventions for people at high risk of developing type 2 diabetes?

    community-level interventions Number PH35 Date issued May 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  4. The Committee recommends that a study estimating utility values using directly observed health-related quality of life values (such as EQ 5D scores) in patients with myelodysplastic syndromes, chronic myelomonocytic leukaemia or acute myeloid leukaemia is conducted.

    acute myeloid leukaemia Number TA218 Date issued March 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  5. Executive team

    Day-to-day decision making is the responsibility of NICE's executive team.

  6. MiraQ for assessing graft flow during coronary artery bypass graft surgery (HTG275)

    Evidence-based recommendations on MiraQ for assessing graft flow during coronary artery bypass graft surgery.

    HealthTech guidance
    Last updated
    5 July 2022
    View recommendations

    Sections for HTG275

  7. What are the most effective and cost effective ways of developing, implementing and assessing tailored and culturally appropriate community-level interventions to prevent type 2 diabetes among people at high risk? This includes people from a range of black and minority ethnic groups and those from lower socioeconomic communities.

    community-level interventions Number PH35 Date issued May 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  8. Ovarian cancer (advanced): bevacizumab 7.5 mg/kg in combination with paclitaxel and carboplatin for first-line treatment (ESUOM21)

    Summary of the evidence on bevacizumab 7.5 mg/kg with paclitaxel and carboplatin for the first-line treatment of advanced ovarian cancer..

    Evidence summary
    Published
    22 October 2013

  9. Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcers (HTG355)

    Evidence-based recommendations on Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcers.

    HealthTech guidance
    Last updated
    19 May 2021
    View recommendations

    Sections for HTG355

  10. Psychosis and schizophrenia in children and young people: recognition and management (CG155)

    This guideline covers recognising and managing psychosis and schizophrenia in children and young people. It aims to improve early recognition of psychosis and schizophrenia so that children and young people can be offered the treatment and care they need to live with the condition.

    Clinical guideline
    Last updated
    26 October 2016
    View recommendations

    Sections for CG155

  11. Current evidence on the efficacy and safety of distal iliotibial band lengthening for refractory greater trochanteric pain syndrome is inadequate in quantity and quality. Therefore this procedure should only be used in the context of research. Research studies should clearly define patient selection, and outcomes should include measures of function and quality of life.

    trochanteric pain syndrome Number IPG375 Date issued January 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  12. Adenoma types and risk of colorectal cancer:- Does the risk of colorectal cancer depend on the type of adenoma?

    Crohn's disease or adenomas Number CG118 Date issued March 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  13. NICE encourages research into endovascular stentgrafting of popliteal aneurysms and may review this procedure on publication of further evidence.

    popliteal aneurysms Number IPG390 Date issued April 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  14. Femoral component design: In adults undergoing hemiarthroplasty for displaced intracapsular hip fracture (including in different subgroups), which femoral component design has the best long-term outcomes?

    Hip fracture: management Number CG124 Date issued June 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    3 February 2023

  15. ClearWay RX for drug delivery to coronary artery thrombotic lesions (MIB55)

    NICE has developed a medtech innovation briefing (MIB) on ClearWay RX for drug delivery to coronary artery thrombotic lesions

    Medtech innovation briefing
    Published
    11 March 2016